Gliotoxin Targets Nuclear NOTCH2 in Human Solid Tumor Derived Cell Lines In Vitro and Inhibits Melanoma Growth in Xenograft Mouse Model

por Hubmann, Rainer, Sieghart, Wolfgang, Schnabl, Susanne, Araghi, Mohammad, Hilgarth, Martin, Reiter, Marlies, Demirtas, Dita, Valent, Peter, Zielinski, Christoph, Jäger, Ulrich, Shehata, Medhat
Publicado 2017

Targeting Nuclear NOTCH2 by Gliotoxin Recovers a Tumor-Suppressor NOTCH3 Activity in CLL

por Hubmann, Rainer, Schnabl, Susanne, Araghi, Mohammad, Schmidl, Christian, Rendeiro, André F., Hilgarth, Martin, Demirtas, Dita, Ali, Farghaly, Staber, Philipp B., Valent, Peter, Zielinski, Christoph, Jäger, Ulrich, Shehata, Medhat
Publicado 2020

UGT2B17 modifies drug response in chronic lymphocytic leukaemia

por Allain, Eric P., Rouleau, Michèle, Vanura, Katrina, Tremblay, Sophie, Vaillancourt, Joanie, Bat, Vincent, Caron, Patrick, Villeneuve, Lyne, Labriet, Adrien, Turcotte, Véronique, Le, Trang, Shehata, Medhat, Schnabl, Susanne, Demirtas, Dita, Hubmann, Rainer, Joly-Beauparlant, Charles, Droit, Arnaud, Jäger, Ulrich, Staber, Philipp B., Lévesque, Eric, Guillemette, Chantal
Publicado 2020

Ludwig Boltzmann Cluster Oncology (LBC ONC): first 10 years and future perspectives

por Valent, Peter, Hadzijusufovic, Emir, Grunt, Thomas, Karlic, Heidrun, Peter, Barbara, Herrmann, Harald, Eisenwort, Gregor, Hoermann, Gregor, Schulenburg, Axel, Willmann, Michael, Hubmann, Rainer, Shehata, Medhat, Selzer, Edgar, Gleixner, Karoline V., Rülicke, Thomas, Sperr, Wolfgang R., Marian, Brigitte, Pfeilstöcker, Michael, Pehamberger, Hubert, Keil, Felix, Jäger, Ulrich, Zielinski, Christoph
Publicado 2018